Copyright
©The Author(s) 2022.
World J Clin Cases. May 6, 2022; 10(13): 4050-4063
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4050
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4050
Group | HM-NE | HM-RE | ||||||
LVEDV (mL) | LVESV (mL) | LVEF (%) | LAESV (mL) | LVEDV (mL) | LVESV (mL) | LVEF (%) | LAESV (mL) | |
Group A | 91.0 ± 17.5a | 31.5 ± 6.9a | 65.2 ± 4.2 | 41.2 ± 10.5a | 86.3 ± 15.9 | 29.6 ± 6.4 | 65.5 ± 3.9 | 39.8 ± 10.6 |
Group B | 187.5 ± 52.3 | 115.6 ± 39.0 | 37.9 ± 11.1 | 68.0 ± 34.6 | 186.1 ± 45.8 | 119.6 ± 40.4 | 35.9 ± 9.4 | 69.4 ± 33.1 |
Group C | 170.3 ± 57.7a | 94.5 ± 40.4 | 45.3 ± 11.8a | 84.9 ± 57.4a | 162.5 ± 56.9 | 95.5 ± 40.2 | 42.5 ± 8.6 | 82.4 ± 57.8 |
Group D | 112.6 ± 27.1a | 47.1 ± 14.8a | 58.3 ± 7.5a | 89.3 ± 45.3 | 105.6 ± 31.6 | 40.1 ± 14.0 | 62.1 ± 5.6 | 83.1 ± 42.1 |
- Citation: Pan CK, Zhao BW, Zhang XX, Pan M, Mao YK, Yang Y. Three-dimensional echocardiographic assessment of left ventricular volume in different heart diseases using a fully automated quantification software. World J Clin Cases 2022; 10(13): 4050-4063
- URL: https://www.wjgnet.com/2307-8960/full/v10/i13/4050.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i13.4050